| Citation: |
HUANG Hui, LI Yuzhen, YUE Guijuan, WANG Qiuling, YU Chuanchuan, BAO Xiuqi, LI Xin. Mechanism of Jinlong Capsule Reversing Paclitaxel Resistance of A549 Cells Investigated by System Biology Technology[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 360-365. DOI: 10.3971/j.issn.1000-8578.2016.05.009
|
To explore the molecular mechanism of Jinlong capsule reversing paclitaxel resistance of paclitaxel-resistant lung adenocarcinoma cell line A549 by system biology technology.
Human Genome U133 Plus 2.0 genechip was used to detect the genes of samples which included A549 paclitaxel-resistant lung adenocarcinoma cell line A549 with Jinlong capsule’s intervention and control group. Then differentially expressed genes were identified based on fold change between the two groups. The topologically significant genes were obtained by one-step overconnectivity test and muti-steps hidden nodes algorithm; the biological function was analyzed by enrichment analysis; the causal network was constructed on Meta Core platform.
Compared with the control group, 203 differentially expressed genes had been identified in Jinlong capsule-treated group(ratio>2). The connection analysis identified 416 topologically significant genes. The causal network model revealed that the target of Jinlong capsule might be associated with down-regulation of the cell cycle genes and up-regulation of immune response.
Jinlong capsule could reverse paclitaxel resistance in paclitaxel-resistant lung adenocarcinoma cell line by A549 regulating cell cycle and immune response.
| [1] |
孙秀玲, 盖晓东. 肿瘤多药耐药逆转剂的研究进展[J]. 广州医学院学报, 2008, 36(4): 60-3.
Sun XL, Ge XD. Research progress of tumor multidrug resistance reversal agents.[J]. Guangzhou Yi Xue Yuan Xue Bao, 2008, 36(4): 60-3.
|
| [1] |
孙秀玲, 盖晓东. 肿瘤多药耐药逆转剂的研究进展[J]. 广州医学 院学报, 2008, 36(4): 60-3. [Sun XL, Ge XD. Research progress of tumor multidrug resistance reversal agents.[J]. Guangzhou Yi Xue Yuan Xue Bao, 2008, 36(4): 60-3.]
|
| [2] |
刘玉琴, 高进, 赵雪梅, 等. 金龙胶囊（JLC）抑制癌细胞转移及复发的实验观察[J]. 中国肿瘤生物治疗杂志, 2001, 8(1): 65-6.
Liu YQ, Gao J, Zhao XM, et al. The experimental observation of the inhibition of tumor cell metastasis and recurrence by JLC[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi, 2001, 8(1): 65-6.
|
| [2] |
Liu YQ, Gao J, Zhao XM, et al. The experimental observation of the inhibition of tumor cell metastasis and recurrence by JLC[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi, 2001, 8(1): 65 -6. [刘玉琴, 高进, 赵雪梅, 等. 金龙胶囊（JLC）抑制癌细胞 转移及复发的实验观察[J]. 中国肿瘤生物治疗杂志, 2001, 8(1): 65 -6.]
|
| [3] |
曲育莹, 岳贵娟, 李建生, 等. 金龙胶囊对耐紫杉醇及长春新碱肿瘤细胞株的逆转及增敏作用[J]. 肿瘤防治研究, 2014, 41(8): 884-7.
Qu YY, Yue GJ, Li JS, et al. Effect of Jinlong Capsules on Reversing Paclitaxel-resistance Vincritine-resistance and Enhancing Sensitivity in Human Cancer Cell Lines[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(8): 884-7.
|
| [3] |
Qu YY, Yue GJ, Li JS, et al. Effect of Jinlong Capsules on Reversing Paclitaxel-resistance Vincritine-resistance and Enhancing Sensitivity in Human Cancer Cell Lines[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(8): 884-7. [曲育莹, 岳贵娟, 李建生, 等. 金龙胶囊对耐紫杉醇及长春新碱肿瘤细胞株的逆转及增敏 作用[J] 肿瘤防治研究, 2014, 41(8): 884-7.]
|
| [4] |
刘文泰, 李丽华, 戴军. 生物芯片技术与中药作用机制研究的思路与方法[J]. 中国中医基础医学杂志, 2008, 14(11): 845-7.
Liu WT, Li LH, Dai J. Thinking Way and Methods of the Biochip Technology and Chinese Herbs Action Mechanisms[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2008, 14(11): 845-7.
|
| [4] |
Liu WT, Li LH, Dai J. Thinking Way and Methods of the Biochip Technology and Chinese Herbs Action Mechanisms[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2008, 14(11): 845-7. [刘文泰, 李 丽华, 戴军. 生物芯片技术与中药作用机制研究的思路与方法 [J] 中国中医基础医学杂志, 2008, 14(11): 845-7.]
|
| [5] |
李伟, 印莉萍. 基因组学相关概念及其研究进展[J]. 生物学通报, 2000, 35(11): 1-3.
Li W, Yin LP. Concept and research advance on genomics[J]. Sheng Wu Xue Tong Bao, 2000, 35(11): 1-3.
|
| [5] |
Li W, Yin LP. Concept and research advance on genomics[J]. Sheng Wu Xue Tong Bao, 2000, 35(11): 1-3. [李伟, 印莉萍. 基因组学 相关概念及其研究进展[J]. 生物学通报, 2000, 35(11): 1-3.]
|
| [6] |
Li SW. Application of system biology in cancer research[J]. Shi Jie Ke Xue, 2011, 2(10): 41-6. [李升伟. 癌症研究中的系统生物 学应用[J]. 世界科学, 2011, 2(10): 41-6.]
|
| [6] |
李升伟. 癌症研究中的系统生物学应用[J]. 世界科学, 2011, 2(10): 41-6.
Li SW. Application of system biology in cancer research[J]. Shi Jie Ke Xue, 2011, 2(10): 41-6.
|
| [7] |
Dezso Z, Nikolsky Y, Nikolskaya T, et al. Identifying disease-specific genes based on their topological significance in protein networks[J]. BMC Syst Biol, 2009, 3: 36.
|
| [7] |
Dezso Z, Nikolsky Y, Nikolskaya T, et al. Identifying diseasespecific genes based on their topological significance in protein networks[J]. BMC Syst Biol, 2009, 3: 36.
|
| [8] |
Nikolsky Y, Kirillow E, Zuev R, et al. Functional analysis of OMICs data and small molecule compounds in an integrated “knowledge-based” platform[J]. Methods Mol Biol, 2009, 563: 177-96.
|
| [8] |
Nikolsky Y, Kirillow E, Zuev R, et al. Functional analysis of OMICs data and small molecule compounds in an integrated “knowledge-based” platform[J]. Methods Mol Biol, 2009, 563: 17 7-96.
|
| [9] |
Yusuf RZ, Duan Z, Lamendola DE, et al. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation[J]. Curr Cancer Drug Targets, 2003, 3(1): 1-19.
|
| [9] |
Yusuf RZ, Duan Z, Lamendola DE, et al. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation[J]. Curr Cancer Drug Targets, 2003, 3(1): 1-19.
|
| [10] |
Zaffaroni N, Silvestrini R, Orlandi L, et al. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells[J]. Br J Cancer, 1998, 77(9): 1378-85.
|
| [10] |
Zaffaroni N, Silvestrini R, Orlandi L, et al. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells[J]. Br J Cancer, 1998, 77(9): 1378-85.
|
| [11] |
Dumontet C, Sikic BI. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death[J]. J Clin Oncol, 1999, 17(3): 1061-70.
|
| [11] |
Dumontet C, Sikic BI. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death[J]. J Clin Oncol, 1999, 17(3): 1061-70.
|
| [12] |
Drukman S, Kavallaris M. Microtubule alterations and resistance to tubulin-binding agents (review)[J]. Int J Oncol, 2002, 21(3): 621-8.
|
| [12] |
Drukman S, Kavallaris M. Microtubule alterations and resistance to tubulin-binding agents (review)[J]. Int J Oncol, 2002, 21(3): 62 1-8.
|
| [13] |
Tan M, Jing T, Lan KH, et al. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis[J]. Mol Cell, 2002, 9(5): 993-1004.
|
| [13] |
Tan M, Jing T, Lan KH, et al. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis[J]. Mol Cell, 2002, 9(5): 99 3-1004.
|
| [14] |
Li LX, Ye SL, Wang YH, et al. Jinlong Capsule high metastasis inhibitory effect on human hepatocellular carcinoma cell line metastasis[J]. Gan Zang, 2011, 16(3): 240-1. [李立新, 叶胜龙, 王 艳红, 等. 金龙胶囊对人肝癌高转移细胞系转移的抑制作用[J]. 肝脏, 2011, 16(3): 240-1.]
|
| [14] |
李立新, 叶胜龙, 王艳红, 等. 金龙胶囊对人肝癌高转移细胞系转移的抑制作用[J].肝脏, 2011, 16(3): 240-1.
Li LX, Ye SL, Wang YH, et al. Jinlong Capsule high metastasis inhibitory effect on human hepatocellular carcinoma cell line metastasis[J]. Gan Zang, 2011, 16(3): 240-1.
|
| [15] |
李要远. 金龙胶囊对人胰腺癌细胞BXPC-3增殖和凋亡的影响[D]. 北京：北京中医药大学, 2012.
Li YY. Studying the impact of proliferation and apoptosis of Jinlong Capsule on human pancreatic cancer BXPC-3 cells[D].Beijing: Beijing Zhong Yi Yao Da Xue, 2012.
|
| [15] |
Li YY. Studying the impact of proliferation and apoptosis of Jinlong Capsule on human pancreatic cancer BXPC-3 cells[D]. Beijing: Beijing Zhong Yi Yao Da Xue, 2012. [李要远. 金龙胶囊 对人胰腺癌细胞BXPC-3增殖和凋亡的影响[D]. 北京：北京中 医药大学, 2012. ]
|
| [16] |
Huang H, Cui XW, Yue GJ, et al. Treatment of gliomatosis cerebri growth with Jinlong Capsules[J]. Zhong Cheng Yao, 2013, 35(9): 39 -43. [黄卉, 崔向微, 岳贵娟, 等. 金龙胶囊治疗脑肿瘤药理机 制研究[J]. 中成药, 2013, 35(9): 39-43.]
|
| [16] |
黄卉, 崔向微, 岳贵娟, 等. 金龙胶囊治疗脑肿瘤药理机制研究[J]. 中成药, 2013, 35(9): 39-43.
Huang H, Cui XW, Yue GJ, et al. Treatment of gliomatosis cerebri growth with Jinlong Capsules[J]. Zhong Cheng Yao, 2013, 35(9): 39-43.
|
| [17] |
Parmar S, Platanias LC. Interferons: mechanisms of action and clinical applications[J]. Curr Opin Oncol, 2003, 15(6): 431-9.
|
| [17] |
Parmar S, Platanias LC. Interferons: mechanisms of action and clinical applications[J]. Curr Opin Oncol, 2003, 15(6): 431-9.
|
| [18] |
Platanias LC. Mechanisms of type-Ⅰ- and type-Ⅱ-interferonmediated signalling[J]. Nat Rev Immunol, 2005, 5(5): 375-86.
|
| [18] |
Platanias LC. Mechanisms of type-Ⅰ- and type-Ⅱ-interferon-mediated signalling[J]. Nat Rev Immunol, 2005, 5(5): 375-86.
|
| [19] |
Fellous A, Ginzburg I, Littauer UZ. Modulation of tubulin mRNA levels by interferon in human lymphoblastoid cells[J]. EMBO J, 1982, 1(7): 835-9.
|
| [19] |
Fellous A, Ginzburg I, Littauer UZ. Modulation of tubulin mRNA levels by interferon in human lymphoblastoid cells[J]. EMBO J, 19 82, 1(7): 835-9.
|
| [20] |
Ward LD, Arakawa T. Stimulation of microtubule assembly by recombinant human interferon-alpha and interferon-gamma[J]. Biochim Biophys Acta, 1989, 1012(3): 317-9.
|
| [20] |
Ward LD, Arakawa T. Stimulation of microtubule assembly by recombinant human interferon-alpha and interferon-gamma[J]. Biochim Biophys Acta, 1989, 1012(3): 317-9.
|
| [21] |
Ebsworth N, Rozengurt E, Taylor-Papadimitriou J. Microtubuledisrupting agents reverse the inhibitory effect of interferon on mitogenesis in 3T3 cells[J]. Exp Cell Res, 1986, 165(1): 255-9.
|
| [21] |
Ebsworth N, Rozengurt E, Taylor-Papadimitriou J. Microtubule-disrupting agents reverse the inhibitory effect of interferon on mitogenesis in 3T3 cells[J]. Exp Cell Res, 1986, 165(1): 255-9.
|
| [22] |
Bani MR, Nicoletti MI, Alkharouf NW, et al. Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts[J]. Mol Cancer Ther, 2004, 3(2): 111-21.
|
| [22] |
Bani MR, Nicoletti MI, Alkharouf NW, et al. Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts[J]. Mol Cancer Ther, 2004, 3(2): 111-21.
|
| [23] |
Luker KE, Pica CM, Schreiber RD, et al. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells[J]. Cancer Res, 2001, 61(17): 6540-7.
|
| [23] |
Luker KE, Pica CM, Schreiber RD, et al. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells[J]. Cancer Res, 2001, 61(17): 6540-7.
|
| [1] | CHEN Lijun, CHEN Jingqi, ZENG Bohang. Correlation of CD68+ Tumor-associated Macrophages Number with Ki-67 Expression and Prognosis of Patients with Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 774-778. DOI: 10.3971/j.issn.1000-8578.2016.09.009 |
| [2] | LI Wen, FENG Yanlin. Valuation of SUVmax, Ki-67, p53 and EGFR in Predicting Effect of Neoadjuvant Chemotherapy on Triple-negative Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 45-47. DOI: 10.3971/j.issn.1000-8578.2016.01.010 |
| [3] | YAN Su, LI Bin, MA Xuxiang, MA Yingcai, XIONG Yuanzhi, GUO Xinjian, MA Yubin, YU Pengjie, WU Junqi, XIE Dawei, ZHAO Junhui, WU Huixian. Clinicopathological Characteristics of Young Gastric Cancer Patients in Hehuang Valley[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 502-505. DOI: 10.3971/j.issn.1000-8578.2015.05.018 |
| [4] | ZHANG Cui-cui, WANG Jing, LI Kai. Characteristics and Prognostic Analysis of 60 Young Patients with Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 274-277. DOI: 10.3971/j.issn.1000-8578.2011.03.009 |
| [5] | LIANG Xu-dong, SHI Xiao-feng, JIA Zong-qi. Detection andSignificance of PTEN, NFκB andKi-67 in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(03): 326-629. DOI: 10.3971/j.issn.1000-8578.2010.03.023 |
| [6] | ZHONG Wei-ming, MA Li-ping, CAI Yong-lin, LIANG Wei, CHEN Wan-sheng, HUANG Zhuo, YU Hong, TAN Bi-fang. Relationship between Expression of Ki-67 Protein and Radiosensitivity of Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 195-196. DOI: 10.3971/j.issn.1000-8578.2010.02.019 |
| [7] | SHI Guo-qing, ZHAO Kui, WANG Hong, LIU Mo-rong. Expression of Gastrin and Ki-67 in Gastric Cancer and Precancerous Pesions[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 756-758. DOI: 10.3971/j.issn.1000-8578.2009.09.011 |
| [8] | HE Yan-jiao, LIU Zhao-xia, LI Hong-li, YU Jin, LI Guang. Expression and Significance of E-cadherin and Ki-67 in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 699-702. DOI: 10.3971/j.issn.1000-8578.2529 |
| [9] | ZHENG Lei, HAN Yue-wu. Antisense Oligodeoxyribonucleotide Target Ki-67 Inhibits Proliferation of Human Hepatocellucar Carcinoma Cell HEPG-7402 in Vitro[J]. Cancer Research on Prevention and Treatment, 2006, 33(12): 862-864. DOI: 10.3971/j.issn.1000-8578.354 |
| [10] | DENG Jie, CAO Dun-wen, LIU Ming-qiu, ZHU Run-qing, CHEN Hong-lei, CHEN Dao-ying, WANG Ji-e. Expression of p73, PTEN and Ki-67 Proteins in Endometrioid Adenocarcinoma and Their Significance[J]. Cancer Research on Prevention and Treatment, 2006, 33(11): 811-813. DOI: 10.3971/j.issn.1000-8578.374 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: